Clopid 75: An Antiplatelet Drug for Cardiovascular Health

Clopid 75 is an antiplatelet medication used to reduce the risk of serious cardiovascular events like myocardial infarction (MI, or heart attack) and stroke in certain patient populations.

How Clopid 75 Works (Pharmacology)

Clopid 75 contains Clopidogrel, which is a prodrug. This means it needs to be metabolized in the body to become active. Its active metabolite then works by irreversibly binding to the P2Y12 class of ADP receptors on platelets. This binding inhibits platelet activation and aggregation (platelets sticking together), which are crucial steps in blood clot formation.

The antiplatelet effect is dose-dependent and can be seen within 2 hours of a single dose. With repeated doses of 75 mg once daily, the inhibition of ADP-induced platelet aggregation reaches a steady state between 3 and 7 days.

Key Indications & Benefits

Clopid 75 is indicated to reduce the rate of MI and stroke in patients with:

• Acute Coronary Syndrome (ACS):
  • Non-ST-segment elevation ACS (unstable angina/non-ST-elevation myocardial infarction - UA/NSTEMI).
  • Acute ST-elevation myocardial infarction (STEMI).
• Recent MI, Recent Stroke, or Established Peripheral Arterial Disease: In patients with a history of these conditions.

Dosage & Administration

Clopid 75 can be taken orally with or without food.

• Acute Coronary Syndrome: For patients needing rapid antiplatelet effect, initiate with a single 300 mg (4 tablets) oral loading dose, then continue with 75 mg once daily. Without a loading dose, the antiplatelet effect will be delayed by several days.
• Recent MI, Recent Stroke, or Established Peripheral Arterial Disease:75 mg once daily orally without a loading dose.

Always consult a registered physician for medication use.

Important Considerations & Warnings

It is crucial to discuss your full medical history with your doctor before taking Clopid 75.

Contraindications:

• Hypersensitivity to clopidogrel or any component of the product.
• Active pathological bleeding, such as peptic ulcer or intracranial hemorrhage.

Side Effects: Clopid is generally well tolerated.

• Common: Bleeding (the most common and significant side effect), diarrhea, gastrointestinal discomfort, hemorrhage, skin reactions.
• Rare: Acquired hemophilia, anemia, angioedema, arthralgia (joint pain), arthritis, bone marrow disorders.
• Potentially Fatal (rare but serious): Thrombotic Thrombocytopenic Purpura (TTP), which requires urgent treatment including plasmapheresis.

Interactions:

• Increased Risk of Bleeding: Concomitant use with NSAIDs, warfarin, selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs) increases the risk of bleeding.
• CYP2C19 Inhibitors: Avoid concomitant use with strong CYP2C19 inhibitors like omeprazole or esomeprazole, as they can reduce the antiplatelet activity of clopidogrel (a prodrug that needs CYP2C19 for activation).
• Repaglinide (CYP2C8 substrates): Avoid concomitant use, as it increases plasma concentrations of Repaglinide.

Pregnancy & Lactation:

• Pregnancy: No adequate and well-controlled studies in pregnant women. Should be used during pregnancy only if clearly needed after careful consideration by a physician.
• Lactation: It is unknown whether clopidogrel is excreted in human breast milk. A decision should be made to discontinue nursing or discontinue the drug, considering the importance of the drug to the mother.

Precautions & Warnings:

• Reduced Antiplatelet Activity: Metabolism to the active metabolite is impaired by genetic variations in CYP2C19 (poor metabolizers) and by drugs that inhibit CYP2C19 (e.g., omeprazole, esomeprazole). This can reduce clopidogrel's effectiveness.
• Increased Bleeding Risk: Clopidogrel inhibits platelet aggregation for the lifetime of the platelet (7-10 days). This increases the risk of bleeding. Platelet transfusions within 4 hours of a loading dose or 2 hours of a maintenance dose may be less effective in restoring hemostasis.
• Discontinuation: Discontinuing Clopid increases the risk of cardiovascular events. For elective surgery with a major bleeding risk, discontinue 5 days prior and resume as soon as hemostasis is achieved.
• Hypersensitivity: Hypersensitivity reactions (including rash, angioedema, or hematologic reaction) have been reported, particularly in patients with a history of hypersensitivity to other thienopyridines.

Use in Special Populations:

• Pediatric: Safety and effectiveness have not been established in pediatric populations.
• Elderly: No dosage adjustment is necessary.

Overdose Effects:

• Overdose may lead to bleeding complications. Platelet transfusion may help restore clotting ability.

Storage Conditions

Keep below 30°C temperature in a dry place. Protected from light. Do not freeze. Keep out of the reach of children.